Navigation Links
ProActive Remedies, LLC Announces Launch of New Allergy Medication
Date:3/27/2008

WINDSOR, Colo., March 27 /PRNewswire/ -- A new patent-pending allergy medication and treatment method is available over the counter as an alternative to allergy shots. ProActive Remedies, LLC announced today that it has begun selling ALLERTHERAPY for the treatment of allergies. The oral immunotherapy spray helps allergy sufferers by building immunity to a wide variety of targeted allergens through the administration of low homeopathic concentrations of such allergens. Over time, this treatment may save money for allergy sufferers through decreased doctor visits, absences, medications, and complications by reducing allergic reactions. ProActive Remedies, LLC sells directly to allergy sufferers through its online store at http://www.allertherapy.com.

To date, ProActive Remedies, LLC has brought to market the ALLERTHERAPY Pollen Mix medication, and anticipates releasing food, environment, and combination mixes this spring. ProActive Remedies, LLC's ALLERTHERAPY line offers an assortment of features including multi-regional, multi-seasonal formulas, a wide variety of targeted allergens, reduced dependence upon allergy medications -- including ALLERTHERAPY itself -- over time, and a 30 Day Unconditional Guarantee. Treatment can reduce the severity of allergic reactions by fifty percent or more. This translates into substantial future savings. Additional benefits to allergy sufferers are the improvements in lifestyle that come with increased allergen tolerance. Improved indoor and outdoor comfort, improved tolerance of pets, and the ability to widen the variety of foods in the food allergy sufferer's diet are among the advantageous results of the ALLERTHERAPY Treatment Method.

According to American Academy of Allergy Asthma & Immunology (AAAAI) estimates, more than twenty percent of Americans are affected by allergic diseases. These allergic diseases are the sixth leading cause of chronic diseases in Americans. In 1996, allergic rhinitis was estimated to have an overall cost of $6 billion in the U.S. The AAAAI also notes that up to 90 percent of those with seasonal allergic rhinitis and up to 80 percent of those with perennial allergic rhinitis are able to successfully treat their condition with immunotherapy. Not all patients qualify for allergy shots, or are able to commit to the rigorous schedule of appointments. The ALLERTHERAPY line of liquid immunotherapy spray is simple to administer and available over the counter as an alternative treatment option. Those with serious allergies or other medical conditions should use ALLERTHERAPY under doctor supervision only. For more information about ALLERTHERAPY, please visit the website at http://www.allertherapy.com. Orders may be placed online or by calling 1 (877) GO-ALLER or 1 (877) 462-5537.

For additional information, contact:

Contact Person: Connie Williams

Company: ProActive Remedies, LLC

Phone: (800) 874-0989 ext. 300

Fax: (703) 637-9893

Email: information@proactiveremedies.com

Online: http://www.allertherapy.com

Phone Orders: (877) GO-ALLER / (877) 462-5537

ProActive Remedies, LLC is dedicated to developing products that empower consumers. The company conducts extensive research to define consumer needs and to develop and market cutting-edge products. The release of ALLERTHERAPY is the result of this process.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ProActive Remedies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia School District Gets Proactive Against MRSA
2. Cancer care providers need to proactively address patients psychological and social needs
3. BJs Charitable Foundation Announces Q4 Donation of More Than $500,000 to Programs That Benefit Children and Families
4. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
5. ThalesNano Announces the Launch of X-Cube Flash(TM), its Next Generation High Temperature and Pressure Continuous Process Reactor
6. Laureate Announces Second Manufacturing Agreement with Cytheris
7. China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results
8. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
9. FEW Announces Legislative Goals for Remainder of 110th Congress; Delivers Fact Sheets to Legislators
10. Hillenbrand Industries, Inc. Announces Pricing of Its Pending Any and All Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009
11. EnergyNow! Announces New Grant Funding to Combat Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, and ... 31st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/26/2017)... ... 26, 2017 , ... Somnoware, a leading provider of digital ... its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration ... platform, initializing devices and importing studies are just one-click operations. This plugin streamlines ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... Peace Agreements being discussed by President Donald Trump and the rest of the world. ... speed up peace talks in the continuous battle between Israel and Palestine. The world’s ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
Breaking Medicine Technology: